These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 21504292)
41. CD200 expression in B-cell chronic lymphoproliferative disorders. El Desoukey NA; Afify RA; Amin DG; Mohammed RF J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604 [TBL] [Abstract][Full Text] [Related]
42. Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry. Abdel-Ghafar AA; El Din El Telbany MA; Mahmoud HM; El-Sakhawy YN Hematol Rep; 2012 Jan; 4(1):e3. PubMed ID: 22567217 [TBL] [Abstract][Full Text] [Related]
43. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079 [TBL] [Abstract][Full Text] [Related]
44. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797 [TBL] [Abstract][Full Text] [Related]
45. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders. Poongodi R; Varma N; Naseem S; Parveen B; Varma S Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884 [TBL] [Abstract][Full Text] [Related]
46. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature. Rai V; Saha A; Gondha S; Manimaran P; Sawhney J J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340 [TBL] [Abstract][Full Text] [Related]
48. Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias. Wells DA; Hall MC; Shulman HM; Loken MR Leukemia; 1998 Dec; 12(12):2015-23. PubMed ID: 9844932 [TBL] [Abstract][Full Text] [Related]
51. Hairy cell leukemia - etiopathogenesis, diagnosis and modern therapeutic approach. Maćkowiak K; Jankowiak M; Szewczyk-Golec K; Hołyńska-Iwan I Biochem Med (Zagreb); 2024 Jun; 34(2):020502. PubMed ID: 38882583 [TBL] [Abstract][Full Text] [Related]
52. Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia. Salem DA; Stetler-Stevenson M Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426 [TBL] [Abstract][Full Text] [Related]
53. Hairy cell leukemia variant with features of intrasinusoidal bone marrow involvement. Ya-In C; Brandwein J; Pantalony D; Chang H Arch Pathol Lab Med; 2005 Mar; 129(3):395-8. PubMed ID: 15737038 [TBL] [Abstract][Full Text] [Related]
54. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. Maitre E; Cornet E; Troussard X Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741 [TBL] [Abstract][Full Text] [Related]
55. CD103-CD23+ classical hair cell leukemia: A case report and review of the literature. Zhao HL; Cui HH; Jin LF; Zhao M; Shen WZ Medicine (Baltimore); 2021 Dec; 100(51):e28262. PubMed ID: 34941102 [TBL] [Abstract][Full Text] [Related]
56. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment. Troussard X; Cornet E Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361 [TBL] [Abstract][Full Text] [Related]
57. Bone marrow and splenic histology in hairy cell leukaemia. Wotherspoon A; Attygalle A; Mendes LS Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898 [TBL] [Abstract][Full Text] [Related]